Optimum Treatment for Drug-Resistant Hypertension

Clinical trial NCT02369081 · UNKNOWN

Trial details

NCT number: NCT02369081
Sponsor: University of Cambridge
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension, Resistant to Conventional Therapy

Start date: 2009-05-01
Primary completion: 2015-07-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.